Antinociceptive and Anti-inflammatory Activities of the Methanolic Extract from the Stem Bark of Lophanthera lactescens

Abstract

Lophanthera lactescens is a medicinal plant commonly used in traditional medicine to relieve fever and pain in inflammatory processes. In the present study, the in vivo antinociceptive and anti-inflammatory effects of the methanolic extract from L. lactescens have been investigated. Antinociceptive activity was evaluated through writhing, formalin, and tail flick tests, while the anti-inflammatory activity was evaluated through paw oedema and air pouch tests in mice. A phytochemical analysis was performed. The extract produced significant inhibition on nociception induced by acetic acid-induced abdominal writhing, formalin, and tail flick tests, and on inflammation induced by oedema and air pouch tests. The previous administration of atropine and glibenclamide reduced the antinociceptive effect produced by the methanolic extract from L. lactescens on the tail flick test in 89% and 66%, respectively. The methanolic extract had no significant effect in the open field test. No intoxication symptoms were observed in the animals administered orally at increasing doses up to 2000 mg/kg. The methanolic extract from the stem bark of L. lactescens possesses antinociceptive properties on models of acute pain induced by chemical and thermal stimuli as well as in models of inflammation and further suggests that this anti-inflammatory activity might involve inhibition of the proinflammatory cytokines, and the antinociceptive activity might involve participation of the cholinergic system and adenosine triphosphate-dependent K+ channel.

Pharmacological evaluation underlying the antinociceptive activity of two new hybrids NSAIDs tetrahydropyran derivatives

“…According to Gonçalves et al , the compound [(±)‐(2,4,6‐cis)‐4‐chloro‐6‐ (naphthalen‐1‐yl)‐tetrahydro‐2H‐pyran‐2‐yl]metanol (precursor of NAP and IBU) showed an effect antinociceptive by acting on κ‐opioid receptors and the NO‐cGMP‐K + ATP pathway. Paton et al also relate the antinociceptive effect of a tetrahydropyran derivative to κ‐opioid receptors.…”

“…The doses of antagonists and inhibitors, administered intraperitoneally and intrathecally, were chosen from the previous data described in the literature .…”

Evaluation of the systemic and spinal antinociceptive effect of a new hybrid NSAID tetrahydropyran derivative

“…injection of 7‐nitroindazole (selective neuronal NO synthase inhibitor), L‐NAME, ODQ, and glibenclamide consisted of 0.005 mL injected by a percutaneous puncture through an intervertebral space at the level of the fifth or sixth lumbar vertebra, according to a previously reported procedure, 39 using a 0.025‐ml Hamilton microsyringe with a 30‐G needle. The doses of antagonists and inhibitors, administered intraperitoneally and intrathecally, were chosen from the previous data described in the literature 11,36,40,41 …”

Analysis of the Anti-inflammatory and Antioxidant Potential of the Fractions Obtained From the Ethyl Acetate Partition of the Leaves of Diplopterys Pubipetala

“…NO acts as a mediator in several functions of the immune system, among them the function of inhibiting the growth of microbial pathogens and protecting tissues damaged by acute systemic inflammation [35]. The production of NO by 3T3 cells, after exposure to the fractions, is detailed in Fig.…”